US Picture Archiving Communications Systems Market

ID: MRFR/HCIT/17957-HCR
100 Pages
Vikita Thakur
Last Updated: May 13, 2026
US Picture Archiving Communication Systems Market Research Report: Size, Share, Trend Analysis By Types (Oncology, PACS, Others) - Growth Outlook & Industry Forecast 2025 To 2035
US Picture Archiving Communications Systems Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)7.63%
2024 Market Size$ 1.13 Million
2025 Market Size$ 1.22 Million
2035 Market Size$ 2.54 Million
Key Players
Siemens Healthineers
GE Healthcare
Philips Healthcare
Agfa-Gevaert Group
Canon Medical Systems
Fujifilm Holdings Corporation
Trends
  • Integration of AI Technologies
  • Telemedicine and Remote Access
  • Regulatory Support and Interoperability
Opportunities
  • Increased Focus on Patient-Centric Care
  • Growing Adoption of Cloud-Based Solutions
  • Regulatory Compliance and Quality Standards
Summary Table of Contents Segmentation Download PDF
  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
    1. 1.1 EXECUTIVE SUMMARY | |
      1. 1.1.1 Market Overview | |
      2. 1.1.2 Key Findings | |
      3. 1.1.3 Market Segmentation | |
      4. 1.1.4 Competitive Landscape | |
      5. 1.1.5 Challenges and Opportunities | |
      6. 1.1.6 Future Outlook 2
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
    1. 2.1 MARKET INTRODUCTION | |
      1. 2.1.1 Definition | |
      2. 2.1.2 Scope of the study | | |
        1. 2.1.2.1 Research Objective | | |
        2. 2.1.2.2 Assumption | | |
        3. 2.1.2.3 Limitations |
    2. 2.2 RESEARCH METHODOLOGY | |
      1. 2.2.1 Overview | |
      2. 2.2.2 Data Mining | |
      3. 2.2.3 Secondary Research | |
      4. 2.2.4 Primary Research | | |
        1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
        2. 2.2.4.2 Breakdown of Primary Respondents | |
      5. 2.2.5 Forecasting Model | |
      6. 2.2.6 Market Size Estimation | | |
        1. 2.2.6.1 Bottom-Up Approach | | |
        2. 2.2.6.2 Top-Down Approach | |
      7. 2.2.7 Data Triangulation | |
      8. 2.2.8 Validation 3
  3. SECTION III: QUALITATIVE ANALYSIS |
    1. 3.1 MARKET DYNAMICS | |
      1. 3.1.1 Overview | |
      2. 3.1.2 Drivers | |
      3. 3.1.3 Restraints | |
      4. 3.1.4 Opportunities |
    2. 3.2 MARKET FACTOR ANALYSIS | |
      1. 3.2.1 Value chain Analysis | |
      2. 3.2.2 Porter's Five Forces Analysis | | |
        1. 3.2.2.1 Bargaining Power of Suppliers | | |
        2. 3.2.2.2 Bargaining Power of Buyers | | |
        3. 3.2.2.3 Threat of New Entrants | | |
        4. 3.2.2.4 Threat of Substitutes | | |
        5. 3.2.2.5 Intensity of Rivalry | |
      3. 3.2.3 COVID-19 Impact Analysis | | |
        1. 3.2.3.1 Market Impact Analysis | | |
        2. 3.2.3.2 Regional Impact | | |
        3. 3.2.3.3 Opportunity and Threat Analysis 4
  4. SECTION IV: QUANTITATIVE ANALYSIS |
    1. 4.1 Life Sciences, BY Type (USD Million) | |
      1. 4.1.1 oncology PACS | |
      2. 4.1.2 cardiology PACS | |
      3. 4.1.3 dental PACS | |
      4. 4.1.4 orthopedics PACS | |
      5. 4.1.5 others |
    2. 4.2 Life Sciences, BY Components (USD Million) | |
      1. 4.2.1 hardware | |
      2. 4.2.2 software | |
      3. 4.2.3 services |
    3. 4.3 Life Sciences, BY Imaging Type (USD Million) | |
      1. 4.3.1 Magnetic Resonance Imaging (MRI) | |
      2. 4.3.2 Computed Tomography (CT) | |
      3. 4.3.3 nuclear imaging | |
      4. 4.3.4 X-ray | |
      5. 4.3.5 ultrasound |
    4. 4.4 Life Sciences, BY Delivery Mode (USD Million) | |
      1. 4.4.1 cloud-based (SAAS) | |
      2. 4.4.2 web-hosted (On-Demand) | |
      3. 4.4.3 on-premise |
    5. 4.5 Life Sciences, BY End-User (USD Million) | |
      1. 4.5.1 hospitals and clinics | |
      2. 4.5.2 healthcare centers | |
      3. 4.5.3 imaging centers | |
      4. 4.5.4 diagnostic centers | |
      5. 4.5.5 clinical research institutions | |
      6. 4.5.6 others 5
  5. SECTION V: COMPETITIVE ANALYSIS |
    1. 5.1 Competitive Landscape | |
      1. 5.1.1 Overview | |
      2. 5.1.2 Competitive Analysis | |
      3. 5.1.3 Market share Analysis | |
      4. 5.1.4 Major Growth Strategy in the Life Sciences | |
      5. 5.1.5 Competitive Benchmarking | |
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Life Sciences | |
      7. 5.1.7 Key developments and growth strategies | | |
        1. 5.1.7.1 New Product Launch/Service Deployment | | |
        2. 5.1.7.2 Merger & Acquisitions | | |
        3. 5.1.7.3 Joint Ventures | |
      8. 5.1.8 Major Players Financial Matrix | | |
        1. 5.1.8.1 Sales and Operating Income | | |
        2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
    2. 5.2 Company Profiles | |
      1. 5.2.1 Siemens Healthineers (DE) | | |
        1. 5.2.1.1 Financial Overview | | |
        2. 5.2.1.2 Products Offered | | |
        3. 5.2.1.3 Key Developments | | |
        4. 5.2.1.4 SWOT Analysis | | |
        5. 5.2.1.5 Key Strategies | |
      2. 5.2.2 GE Healthcare (US) | | |
        1. 5.2.2.1 Financial Overview | | |
        2. 5.2.2.2 Products Offered | | |
        3. 5.2.2.3 Key Developments | | |
        4. 5.2.2.4 SWOT Analysis | | |
        5. 5.2.2.5 Key Strategies | |
      3. 5.2.3 Philips Healthcare (NL) | | |
        1. 5.2.3.1 Financial Overview | | |
        2. 5.2.3.2 Products Offered | | |
        3. 5.2.3.3 Key Developments | | |
        4. 5.2.3.4 SWOT Analysis | | |
        5. 5.2.3.5 Key Strategies | |
      4. 5.2.4 Agfa-Gevaert Group (BE) | | |
        1. 5.2.4.1 Financial Overview | | |
        2. 5.2.4.2 Products Offered | | |
        3. 5.2.4.3 Key Developments | | |
        4. 5.2.4.4 SWOT Analysis | | |
        5. 5.2.4.5 Key Strategies | |
      5. 5.2.5 Canon Medical Systems (JP) | | |
        1. 5.2.5.1 Financial Overview | | |
        2. 5.2.5.2 Products Offered | | |
        3. 5.2.5.3 Key Developments | | |
        4. 5.2.5.4 SWOT Analysis | | |
        5. 5.2.5.5 Key Strategies | |
      6. 5.2.6 Fujifilm Holdings Corporation (JP) | | |
        1. 5.2.6.1 Financial Overview | | |
        2. 5.2.6.2 Products Offered | | |
        3. 5.2.6.3 Key Developments | | |
        4. 5.2.6.4 SWOT Analysis | | |
        5. 5.2.6.5 Key Strategies | |
      7. 5.2.7 Carestream Health (US) | | |
        1. 5.2.7.1 Financial Overview | | |
        2. 5.2.7.2 Products Offered | | |
        3. 5.2.7.3 Key Developments | | |
        4. 5.2.7.4 SWOT Analysis | | |
        5. 5.2.7.5 Key Strategies | |
      8. 5.2.8 Hologic, Inc. (US) | | |
        1. 5.2.8.1 Financial Overview | | |
        2. 5.2.8.2 Products Offered | | |
        3. 5.2.8.3 Key Developments | | |
        4. 5.2.8.4 SWOT Analysis | | |
        5. 5.2.8.5 Key Strategies |
    3. 5.3 Appendix | |
      1. 5.3.1 References | |
      2. 5.3.2 Related Reports 6 LIST OF FIGURES |
    4. 6.1 MARKET SYNOPSIS |
    5. 6.2 US MARKET ANALYSIS BY TYPE |
    6. 6.3 US MARKET ANALYSIS BY COMPONENTS |
    7. 6.4 US MARKET ANALYSIS BY IMAGING TYPE |
    8. 6.5 US MARKET ANALYSIS BY DELIVERY MODE |
    9. 6.6 US MARKET ANALYSIS BY END-USER |
    10. 6.7 KEY BUYING CRITERIA OF LIFE SCIENCES |
    11. 6.8 RESEARCH PROCESS OF MRFR |
    12. 6.9 DRO ANALYSIS OF LIFE SCIENCES |
    13. 6.10 DRIVERS IMPACT ANALYSIS: LIFE SCIENCES |
    14. 6.11 RESTRAINTS IMPACT ANALYSIS: LIFE SCIENCES |
    15. 6.12 SUPPLY / VALUE CHAIN: LIFE SCIENCES |
    16. 6.13 LIFE SCIENCES, BY TYPE, 2024 (% SHARE) |
    17. 6.14 LIFE SCIENCES, BY TYPE, 2024 TO 2035 (USD Million) |
    18. 6.15 LIFE SCIENCES, BY COMPONENTS, 2024 (% SHARE) |
    19. 6.16 LIFE SCIENCES, BY COMPONENTS, 2024 TO 2035 (USD Million) |
    20. 6.17 LIFE SCIENCES, BY IMAGING TYPE, 2024 (% SHARE) |
    21. 6.18 LIFE SCIENCES, BY IMAGING TYPE, 2024 TO 2035 (USD Million) |
    22. 6.19 LIFE SCIENCES, BY DELIVERY MODE, 2024 (% SHARE) |
    23. 6.20 LIFE SCIENCES, BY DELIVERY MODE, 2024 TO 2035 (USD Million) |
    24. 6.21 LIFE SCIENCES, BY END-USER, 2024 (% SHARE) |
    25. 6.22 LIFE SCIENCES, BY END-USER, 2024 TO 2035 (USD Million) |
    26. 6.23 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
    27. 7.1 LIST OF ASSUMPTIONS | |
      1. 7.1.1 |
    28. 7.2 US MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.2.1 BY TYPE, 2025-2035 (USD Million) | |
      2. 7.2.2 BY COMPONENTS, 2025-2035 (USD Million) | |
      3. 7.2.3 BY IMAGING TYPE, 2025-2035 (USD Million) | |
      4. 7.2.4 BY DELIVERY MODE, 2025-2035 (USD Million) | |
      5. 7.2.5 BY END-USER, 2025-2035 (USD Million) |
    29. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
      1. 7.3.1 |
    30. 7.4 ACQUISITION/PARTNERSHIP | |

US Picture Archiving Communications Systems Market Segmentation

US Picture Archiving Communications Systems Market By Type (USD Million, 2025-2035)

  • oncology PACS
  • cardiology PACS
  • dental PACS
  • orthopedics PACS
  • others

US Picture Archiving Communications Systems Market By Components (USD Million, 2025-2035)

  • hardware
  • software
  • services

US Picture Archiving Communications Systems Market By Imaging Type (USD Million, 2025-2035)

  • Magnetic Resonance Imaging (MRI)
  • Computed Tomography (CT)
  • nuclear imaging
  • X-ray
  • ultrasound

US Picture Archiving Communications Systems Market By Delivery Mode (USD Million, 2025-2035)

  • cloud-based (SAAS)
  • web-hosted (On-Demand)
  • on-premise

US Picture Archiving Communications Systems Market By End-User (USD Million, 2025-2035)

  • hospitals and clinics
  • healthcare centers
  • imaging centers
  • diagnostic centers
  • clinical research institutions
  • others

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.